Sign In to Follow Application
View All Documents & Correspondence

Composition Comprising Indole 3 Acetic Acid And Uses Thereof

Abstract: The present invention relates to anti-aging composition comprising indole-3-acetic acid and oleanolic acid. Also disclosed herein are the methods of using such a composition for preventing and reducing the signs of skin aging.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
26 June 2013
Publication Number
24/2016
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC Limited, ITC Life Sciences & Technology Centre, #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560058

Inventors

1. BANDYOPADHYAY, Balaji
ITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058
2. KUMARI, Deva
ITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058
3. JOIS, Prashanth
ITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058
4. CHANDRASEKHARAN, Lakshmanan Chittur
ITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Specification

CLIAMS:1.A cosmetic composition for preventing and reducing signs of skin aging comprising:
a)0.000002% to 0.00044% (w/w) of indole 3-acetic acid;
b)0.00005% to 1% (w/w) of oleanolic acid; and
c)70% to 99.9% (w/w) of a cosmetically acceptable carrier.
2.The cosmetic composition as claimed in claim 1, wherein the signs of skin aging are selected from the group consisting of wrinkles, fine lines, sagging skin, lack of radiance, and combinations thereof.
3.The cosmetic composition as claimed in claim 1, wherein the cosmetic composition comprises 0.0001% (w/w) of indole 3-acetic acid.
4.The cosmetic composition as claimed in claim 1, wherein the cosmetic composition comprises 0.0001% (w/w) of oleanolic acid.
5.The cosmetic composition as claimed in claim 1, wherein the cosmetic composition is formulated in a form selected from the group consisting of skin cream, skin lotion, sunscreen lotion, anti-aging product, skin foundation, gel, skin spot correction product, serums, moisturizing spray, facial scrub, and facial peel.
6.A method for preventing and reducing signs of skin aging by topically administering a cosmetic composition, wherein the cosmetic composition comprises:
a)0.000002% to 0.00044% (w/w) of indole 3-acetic acid;
b)0.00005% to 1% (w/w) of oleanolic acid; and
c)70% to 99.9% (w/w) of a cosmetically acceptable carrier.
7.The method as claimed in claim 6, wherein the signs of skin aging are selected from the group consisting of wrinkles, fine lines, sagging skin, lack of radiance, and combinations thereof.
8.The method as claimed in claim 6, wherein the cosmetic composition comprises 0.0001% (w/w) of indole 3-acetic acid.
9.The method as claimed in claim 6, wherein the cosmetic composition comprises 0.0001% (w/w) of oleanolic acid.
,TagSPECI:As Attached

Documents

Application Documents

# Name Date
1 2805-CHE-2013-Correspondence to notify the Controller [08-07-2020(online)].pdf 2020-07-08
1 SPEC.pdf 2013-06-27
2 FORM 5.pdf 2013-06-27
2 2805-CHE-2013-US(14)-HearingNotice-(HearingDate-09-07-2020).pdf 2020-06-11
3 FORM 3.pdf 2013-06-27
3 2805-CHE-2013-ABSTRACT [05-07-2019(online)].pdf 2019-07-05
4 FIG.pdf 2013-06-27
4 2805-CHE-2013-DRAWING [05-07-2019(online)].pdf 2019-07-05
5 2805-CHE-2013-FER_SER_REPLY [05-07-2019(online)].pdf 2019-07-05
5 2805-CHE-2013 POWER OF ATTORNEY 23-07-2013.pdf 2013-07-23
6 2805-CHE-2013-OTHERS [05-07-2019(online)].pdf 2019-07-05
6 2805-CHE-2013 CORRESPONDENCE OTHERS 23-07-2013.pdf 2013-07-23
7 2805-CHE-2013-FER.pdf 2019-01-09
7 2805-CHE-2013 FORM -1 25-07-2013.pdf 2013-07-25
8 Form 18 [12-01-2017(online)].pdf 2017-01-12
8 2805-CHE-2013 CORRESPONDENCE OTHERS 25-07-2013.pdf 2013-07-25
9 Form 18 [12-01-2017(online)].pdf 2017-01-12
9 2805-CHE-2013 CORRESPONDENCE OTHERS 25-07-2013.pdf 2013-07-25
10 2805-CHE-2013 FORM -1 25-07-2013.pdf 2013-07-25
10 2805-CHE-2013-FER.pdf 2019-01-09
11 2805-CHE-2013-OTHERS [05-07-2019(online)].pdf 2019-07-05
11 2805-CHE-2013 CORRESPONDENCE OTHERS 23-07-2013.pdf 2013-07-23
12 2805-CHE-2013-FER_SER_REPLY [05-07-2019(online)].pdf 2019-07-05
12 2805-CHE-2013 POWER OF ATTORNEY 23-07-2013.pdf 2013-07-23
13 FIG.pdf 2013-06-27
13 2805-CHE-2013-DRAWING [05-07-2019(online)].pdf 2019-07-05
14 FORM 3.pdf 2013-06-27
14 2805-CHE-2013-ABSTRACT [05-07-2019(online)].pdf 2019-07-05
15 FORM 5.pdf 2013-06-27
15 2805-CHE-2013-US(14)-HearingNotice-(HearingDate-09-07-2020).pdf 2020-06-11
16 SPEC.pdf 2013-06-27
16 2805-CHE-2013-Correspondence to notify the Controller [08-07-2020(online)].pdf 2020-07-08

Search Strategy

1 2805-CHE-2013Searchstrategy_04-01-2019.pdf